Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1136/gutjnl-2021-324116

Type

Journal article

Journal

Gut

Publication Date

12/2021

Volume

70

Pages

2398 - 2400

Addresses

Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK colleen.mcgregor@ndm.ox.ac.uk.

Keywords

Humans, Inflammatory Bowel Diseases, Pandemics, Antibodies, Monoclonal, Humanized, Infliximab, United Kingdom, COVID-19, SARS-CoV-2